Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention
Dominick J. Angiolillo, Davide Cao, Samantha Sartori, Usman Baber, George Dangas, Zhongjie Zhang, Birgit Vogel, Vijay Kunadian, Carlo Briguori, David J. Cohen, Timothy Collier, Dariusz Dudek, Michael Gibson, Robert Gil, Kurt Huber, Upendra Kaul, Ran Kornowski, Mitchell W. Krucoff, Alfonso Ielasi, Giulio Stefanini, Carlo Andrea Pivato, Shamir R. Mehta, David J. Moliterno, E. Magnus Ohman, Javier Escaned, Gennaro Sardella, Samin K. Sharma, Richard Shlofmitz, Giora Weisz, Bernhard Witzenbichler, Philippe Gabríel Steg, Stuart Pocock, Roxana Mehran
Topics & Concepts
TicagrelorMedicineDiscontinuationPercutaneous coronary interventionAspirinInternal medicineMyocardial infarctionConventional PCIStroke (engine)CardiologyCoronary artery diseaseMechanical engineeringEngineeringAntiplatelet Therapy and Cardiovascular DiseasesAtrial Fibrillation Management and OutcomesAcute Myocardial Infarction Research